AstraZeneca's (NASDAQ:AZN) selloff on Tuesday in response to reports that the company is facing a fraud investigation in ...

An insurance fraud investigation linked to AstraZeneca (AZN) expands in China involving dozens of senior executives. Read ...

BMO Capital Markets analyst Etzer Darout in a note to investors said the insurance fraud probe represents a “headline risk” ...

Pharmaceutical giant AstraZeneca said that the head of its China operations had been detained, after reports the firm was ...

Leon Wang, executive vice president in charge of China and the broader Asian region, is being detained while the Chinese ...

AstraZeneca stock tumbles as Chinese probe widens, implicating executives in insurance fraud and drug import violations ...

Astra saw £14.4bn wiped off its value after Chinese media said dozens of managers were implicated in a scandal.

AstraZeneca (AZN) stock falls as a Chinese probe into drug importations and data privacy implicates senior and former ...

AstraZeneca said its China president Leon Wang is under investigation and the drugmaker would cooperate with Chinese ...

The pharma giant confirmed that Wang Lei, the executive vice president who oversaw AstraZeneca’s rapid expansion in China, is ...

Nov 5 (Reuters) - AstraZeneca (AZN.L), opens new tab shares on Tuesday recorded their worst day since March 2020 after a report that dozens of the drugmaker's senior executives in China could be ...

With an array of new medicines and medical devices on display global medical companies are looking to tap further into the ...